Oct 11, 2018 · 1h 4m · y-combinator

Cannabis Startup Founders David Hua and Vincent Ning on Legalization, Banking, and Industry Trends · Y Combinator

David Hua · 32m spoken Vincent Ning · 17m spoken Craig Cannon · 6m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this Y Combinator podcast episode, Meadow co-founder David Hua and Nabus co-founder Vincent Ning discuss the evolution of legal cannabis, covering consumer product trends, complex supply chain logistics, and unique fundraising hurdles. They share insights into navigating strict state regulations, federal banking exclusions, and the broader cultural shift from prohibition stigma toward social equity and mainstream wellness.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →

The partners as informed peer 1.9 Guest teaching 6.3 Guest disagreement 0.5 The partners pushing back 0.1
05100:0015:0030:0045:001:00:000:57–4:09 · The partners as informed peer 1/10 Third-Party Cannabis Distribution Model Craig asks basic questions about strain aroma indicating strain or potency. David Hua and Vincent Ning educate him on terpene profiles, sativas vs indicas, and how live resin concentrates are made and measured.4:09–9:53 · The partners as informed peer 2/10 Microdosing and Edible Trends for New Consumers Craig shares his own experience with low-dose edibles versus smoking. The guests break down liver metabolization, onset timing, vape concentrates, and how microdosing caters to the modern mainstream consumer.9:53–14:13 · The partners as informed peer 1/10 Demographics and the Rise of Baby Boomers Craig prompts for demographic trends and asks for an explanation of CBD. David and Vincent explain the surge in baby boomer adoption and break down the science of cannabinoids and the entourage effect.14:13–16:29 · The partners as informed peer 1/10 Terpene Lexicon and Extraction Methods Craig asks how specific compounds like CBD are isolated without pulling other elements. David gives a technical rundown of solventless ice-water hash methods versus chemical extractions like CO2 and butane distillation.16:29–19:05 · The partners as informed peer 2/10 Business Models: Meadow and Nabus Craig inquires why both founders avoided direct product manufacturing. Vincent details the capital-intensive nature of equipment and the friction around fundraising with a Type 11 distribution license.19:05–21:57 · The partners as informed peer 3/10 Y Combinator Experience and Pitch Strategy Craig and David discuss the Y Combinator interview process for cannabis software and the transition from Prop 215 paperless practices to 7-year compliance tracking.21:57–23:59 · The partners as informed peer 2/10 Investor Mindset & Due Diligence Craig asks about investor composition and industry growth stats. The guests explain rolling angel raises, investor educational diligence, and California's historical share of total US supply.23:59–28:53 · The partners as informed peer 2/10 California Market Dominance & Local Regulatory Hurdles Craig questions why there is no dominant national or statewide brand like Marlboro or Budweiser. David and Vincent explain the fragmented dual-licensing regime where municipal opt-outs strangle supply chains.28:53–30:55 · The partners as informed peer 2/10 State Comparisons and Canadian Federal Legalization Craig asks about other states and Canada. David and Vincent explain the influx of capital from publicly listed Canadian licensed producers moving into California.30:55–33:09 · The partners as informed peer 2/10 The Banking Crisis in the Cannabis Industry Craig asks how operators bank cash without federal FDIC support. Vincent and David outline credit unions, multiple accounts, and pending delivery regulations allowing mobile inventory.33:09–35:12 · The partners as informed peer 1/10 Warehouse Logistics and Distributor Responsibilities Craig is surprised to hear raw flower arrives in trash bags. Vincent clarifies the legal mandate that makes distributors the sole tax and compliance gatekeepers between farms and dispensaries.35:12–37:51 · The partners as informed peer 2/10 Taxation Burden and Illicit Market Resurgence Craig asks if farmers capture the upside of retail prices. David and Vincent show how compounding cultivation, excise, and gross receipt taxes force medical consumers back to the illicit market.37:51–42:39 · The partners as informed peer 2/10 Medical Cards vs Adult-Use Realities Craig asks why anyone still gets medical cards. David and Vincent describe the high card fees, Phase 2 pesticide testing wipeouts, and dispensary demo day marketing dynamics.42:39–44:52 · The partners as informed peer 2/10 Future Outlook: Regulation, Interstate Expansion, and M&A Craig prompts for a 5-to-10-year industry vision. Vincent outlines the interstate expansion barrier requiring siloed state-level entities and predatory Canadian M&A structures.44:52–49:20 · The partners as informed peer 2/10 Long-Term Vision: Unlimited Grows and Corporate Entry David details the impending expiration of the 1-acre grow cap in 2023, the rise of corporate alcohol/tobacco conglomerates, and comparisons to the dot-com bubble.49:20–52:50 · The partners as informed peer 2/10 Cultural Evolution, Stigma, and Media Shift Craig asks if stoner stereotypes like Cheech & Chong hurt or helped the movement. Vincent and David discuss historical advocacy, digital advertising bans, and mainstreaming via public figures.52:50–1:00:41 · The partners as informed peer 3/10 Medical Origins, Psychedelic Parallels, and Social Equity Craig brings up Michael Pollan's book on psychedelics and social equity. David and Vincent explain Prop 215's roots in the San Francisco AIDS crisis, SB 1294 grant funding, and municipal social equity quotas.0:57–4:09 · Guest teaching 7/10 Third-Party Cannabis Distribution Model Craig asks basic questions about strain aroma indicating strain or potency. David Hua and Vincent Ning educate him on terpene profiles, sativas vs indicas, and how live resin concentrates are made and measured.4:09–9:53 · Guest teaching 6/10 Microdosing and Edible Trends for New Consumers Craig shares his own experience with low-dose edibles versus smoking. The guests break down liver metabolization, onset timing, vape concentrates, and how microdosing caters to the modern mainstream consumer.9:53–14:13 · Guest teaching 8/10 Demographics and the Rise of Baby Boomers Craig prompts for demographic trends and asks for an explanation of CBD. David and Vincent explain the surge in baby boomer adoption and break down the science of cannabinoids and the entourage effect.14:13–16:29 · Guest teaching 7/10 Terpene Lexicon and Extraction Methods Craig asks how specific compounds like CBD are isolated without pulling other elements. David gives a technical rundown of solventless ice-water hash methods versus chemical extractions like CO2 and butane distillation.16:29–19:05 · Guest teaching 6/10 Business Models: Meadow and Nabus Craig inquires why both founders avoided direct product manufacturing. Vincent details the capital-intensive nature of equipment and the friction around fundraising with a Type 11 distribution license.19:05–21:57 · Guest teaching 5/10 Y Combinator Experience and Pitch Strategy Craig and David discuss the Y Combinator interview process for cannabis software and the transition from Prop 215 paperless practices to 7-year compliance tracking.21:57–23:59 · Guest teaching 5/10 Investor Mindset & Due Diligence Craig asks about investor composition and industry growth stats. The guests explain rolling angel raises, investor educational diligence, and California's historical share of total US supply.23:59–28:53 · Guest teaching 7/10 California Market Dominance & Local Regulatory Hurdles Craig questions why there is no dominant national or statewide brand like Marlboro or Budweiser. David and Vincent explain the fragmented dual-licensing regime where municipal opt-outs strangle supply chains.28:53–30:55 · Guest teaching 6/10 State Comparisons and Canadian Federal Legalization Craig asks about other states and Canada. David and Vincent explain the influx of capital from publicly listed Canadian licensed producers moving into California.30:55–33:09 · Guest teaching 6/10 The Banking Crisis in the Cannabis Industry Craig asks how operators bank cash without federal FDIC support. Vincent and David outline credit unions, multiple accounts, and pending delivery regulations allowing mobile inventory.33:09–35:12 · Guest teaching 7/10 Warehouse Logistics and Distributor Responsibilities Craig is surprised to hear raw flower arrives in trash bags. Vincent clarifies the legal mandate that makes distributors the sole tax and compliance gatekeepers between farms and dispensaries.35:12–37:51 · Guest teaching 7/10 Taxation Burden and Illicit Market Resurgence Craig asks if farmers capture the upside of retail prices. David and Vincent show how compounding cultivation, excise, and gross receipt taxes force medical consumers back to the illicit market.37:51–42:39 · Guest teaching 6/10 Medical Cards vs Adult-Use Realities Craig asks why anyone still gets medical cards. David and Vincent describe the high card fees, Phase 2 pesticide testing wipeouts, and dispensary demo day marketing dynamics.42:39–44:52 · Guest teaching 6/10 Future Outlook: Regulation, Interstate Expansion, and M&A Craig prompts for a 5-to-10-year industry vision. Vincent outlines the interstate expansion barrier requiring siloed state-level entities and predatory Canadian M&A structures.44:52–49:20 · Guest teaching 7/10 Long-Term Vision: Unlimited Grows and Corporate Entry David details the impending expiration of the 1-acre grow cap in 2023, the rise of corporate alcohol/tobacco conglomerates, and comparisons to the dot-com bubble.49:20–52:50 · Guest teaching 5/10 Cultural Evolution, Stigma, and Media Shift Craig asks if stoner stereotypes like Cheech & Chong hurt or helped the movement. Vincent and David discuss historical advocacy, digital advertising bans, and mainstreaming via public figures.52:50–1:00:41 · Guest teaching 7/10 Medical Origins, Psychedelic Parallels, and Social Equity Craig brings up Michael Pollan's book on psychedelics and social equity. David and Vincent explain Prop 215's roots in the San Francisco AIDS crisis, SB 1294 grant funding, and municipal social equity quotas.0:57–4:09 · Guest disagreement 1/10 Third-Party Cannabis Distribution Model Craig asks basic questions about strain aroma indicating strain or potency. David Hua and Vincent Ning educate him on terpene profiles, sativas vs indicas, and how live resin concentrates are made and measured.4:09–9:53 · Guest disagreement 1/10 Microdosing and Edible Trends for New Consumers Craig shares his own experience with low-dose edibles versus smoking. The guests break down liver metabolization, onset timing, vape concentrates, and how microdosing caters to the modern mainstream consumer.9:53–14:13 · Guest disagreement 1/10 Demographics and the Rise of Baby Boomers Craig prompts for demographic trends and asks for an explanation of CBD. David and Vincent explain the surge in baby boomer adoption and break down the science of cannabinoids and the entourage effect.14:13–16:29 · Guest disagreement 1/10 Terpene Lexicon and Extraction Methods Craig asks how specific compounds like CBD are isolated without pulling other elements. David gives a technical rundown of solventless ice-water hash methods versus chemical extractions like CO2 and butane distillation.16:29–19:05 · Guest disagreement 0/10 Business Models: Meadow and Nabus Craig inquires why both founders avoided direct product manufacturing. Vincent details the capital-intensive nature of equipment and the friction around fundraising with a Type 11 distribution license.19:05–21:57 · Guest disagreement 0/10 Y Combinator Experience and Pitch Strategy Craig and David discuss the Y Combinator interview process for cannabis software and the transition from Prop 215 paperless practices to 7-year compliance tracking.21:57–23:59 · Guest disagreement 0/10 Investor Mindset & Due Diligence Craig asks about investor composition and industry growth stats. The guests explain rolling angel raises, investor educational diligence, and California's historical share of total US supply.23:59–28:53 · Guest disagreement 2/10 California Market Dominance & Local Regulatory Hurdles Craig questions why there is no dominant national or statewide brand like Marlboro or Budweiser. David and Vincent explain the fragmented dual-licensing regime where municipal opt-outs strangle supply chains.28:53–30:55 · Guest disagreement 0/10 State Comparisons and Canadian Federal Legalization Craig asks about other states and Canada. David and Vincent explain the influx of capital from publicly listed Canadian licensed producers moving into California.30:55–33:09 · Guest disagreement 0/10 The Banking Crisis in the Cannabis Industry Craig asks how operators bank cash without federal FDIC support. Vincent and David outline credit unions, multiple accounts, and pending delivery regulations allowing mobile inventory.33:09–35:12 · Guest disagreement 0/10 Warehouse Logistics and Distributor Responsibilities Craig is surprised to hear raw flower arrives in trash bags. Vincent clarifies the legal mandate that makes distributors the sole tax and compliance gatekeepers between farms and dispensaries.35:12–37:51 · Guest disagreement 1/10 Taxation Burden and Illicit Market Resurgence Craig asks if farmers capture the upside of retail prices. David and Vincent show how compounding cultivation, excise, and gross receipt taxes force medical consumers back to the illicit market.37:51–42:39 · Guest disagreement 0/10 Medical Cards vs Adult-Use Realities Craig asks why anyone still gets medical cards. David and Vincent describe the high card fees, Phase 2 pesticide testing wipeouts, and dispensary demo day marketing dynamics.42:39–44:52 · Guest disagreement 0/10 Future Outlook: Regulation, Interstate Expansion, and M&A Craig prompts for a 5-to-10-year industry vision. Vincent outlines the interstate expansion barrier requiring siloed state-level entities and predatory Canadian M&A structures.44:52–49:20 · Guest disagreement 1/10 Long-Term Vision: Unlimited Grows and Corporate Entry David details the impending expiration of the 1-acre grow cap in 2023, the rise of corporate alcohol/tobacco conglomerates, and comparisons to the dot-com bubble.49:20–52:50 · Guest disagreement 1/10 Cultural Evolution, Stigma, and Media Shift Craig asks if stoner stereotypes like Cheech & Chong hurt or helped the movement. Vincent and David discuss historical advocacy, digital advertising bans, and mainstreaming via public figures.52:50–1:00:41 · Guest disagreement 0/10 Medical Origins, Psychedelic Parallels, and Social Equity Craig brings up Michael Pollan's book on psychedelics and social equity. David and Vincent explain Prop 215's roots in the San Francisco AIDS crisis, SB 1294 grant funding, and municipal social equity quotas.0:57–4:09 · The partners pushing back 0/10 Third-Party Cannabis Distribution Model Craig asks basic questions about strain aroma indicating strain or potency. David Hua and Vincent Ning educate him on terpene profiles, sativas vs indicas, and how live resin concentrates are made and measured.4:09–9:53 · The partners pushing back 1/10 Microdosing and Edible Trends for New Consumers Craig shares his own experience with low-dose edibles versus smoking. The guests break down liver metabolization, onset timing, vape concentrates, and how microdosing caters to the modern mainstream consumer.9:53–14:13 · The partners pushing back 0/10 Demographics and the Rise of Baby Boomers Craig prompts for demographic trends and asks for an explanation of CBD. David and Vincent explain the surge in baby boomer adoption and break down the science of cannabinoids and the entourage effect.14:13–16:29 · The partners pushing back 0/10 Terpene Lexicon and Extraction Methods Craig asks how specific compounds like CBD are isolated without pulling other elements. David gives a technical rundown of solventless ice-water hash methods versus chemical extractions like CO2 and butane distillation.16:29–19:05 · The partners pushing back 0/10 Business Models: Meadow and Nabus Craig inquires why both founders avoided direct product manufacturing. Vincent details the capital-intensive nature of equipment and the friction around fundraising with a Type 11 distribution license.19:05–21:57 · The partners pushing back 0/10 Y Combinator Experience and Pitch Strategy Craig and David discuss the Y Combinator interview process for cannabis software and the transition from Prop 215 paperless practices to 7-year compliance tracking.21:57–23:59 · The partners pushing back 0/10 Investor Mindset & Due Diligence Craig asks about investor composition and industry growth stats. The guests explain rolling angel raises, investor educational diligence, and California's historical share of total US supply.23:59–28:53 · The partners pushing back 1/10 California Market Dominance & Local Regulatory Hurdles Craig questions why there is no dominant national or statewide brand like Marlboro or Budweiser. David and Vincent explain the fragmented dual-licensing regime where municipal opt-outs strangle supply chains.28:53–30:55 · The partners pushing back 0/10 State Comparisons and Canadian Federal Legalization Craig asks about other states and Canada. David and Vincent explain the influx of capital from publicly listed Canadian licensed producers moving into California.30:55–33:09 · The partners pushing back 0/10 The Banking Crisis in the Cannabis Industry Craig asks how operators bank cash without federal FDIC support. Vincent and David outline credit unions, multiple accounts, and pending delivery regulations allowing mobile inventory.33:09–35:12 · The partners pushing back 0/10 Warehouse Logistics and Distributor Responsibilities Craig is surprised to hear raw flower arrives in trash bags. Vincent clarifies the legal mandate that makes distributors the sole tax and compliance gatekeepers between farms and dispensaries.35:12–37:51 · The partners pushing back 0/10 Taxation Burden and Illicit Market Resurgence Craig asks if farmers capture the upside of retail prices. David and Vincent show how compounding cultivation, excise, and gross receipt taxes force medical consumers back to the illicit market.37:51–42:39 · The partners pushing back 0/10 Medical Cards vs Adult-Use Realities Craig asks why anyone still gets medical cards. David and Vincent describe the high card fees, Phase 2 pesticide testing wipeouts, and dispensary demo day marketing dynamics.42:39–44:52 · The partners pushing back 0/10 Future Outlook: Regulation, Interstate Expansion, and M&A Craig prompts for a 5-to-10-year industry vision. Vincent outlines the interstate expansion barrier requiring siloed state-level entities and predatory Canadian M&A structures.44:52–49:20 · The partners pushing back 0/10 Long-Term Vision: Unlimited Grows and Corporate Entry David details the impending expiration of the 1-acre grow cap in 2023, the rise of corporate alcohol/tobacco conglomerates, and comparisons to the dot-com bubble.49:20–52:50 · The partners pushing back 0/10 Cultural Evolution, Stigma, and Media Shift Craig asks if stoner stereotypes like Cheech & Chong hurt or helped the movement. Vincent and David discuss historical advocacy, digital advertising bans, and mainstreaming via public figures.52:50–1:00:41 · The partners pushing back 0/10 Medical Origins, Psychedelic Parallels, and Social Equity Craig brings up Michael Pollan's book on psychedelics and social equity. David and Vincent explain Prop 215's roots in the San Francisco AIDS crisis, SB 1294 grant funding, and municipal social equity quotas.

speaking balance: gold is the partners, purple is the guest (3 minute bins)

0:00 · the partners 0% · guest 100%0:00 · the partners 0% · guest 100%3:00 · the partners 0% · guest 100%3:00 · the partners 0% · guest 100%6:00 · the partners 0% · guest 100%6:00 · the partners 0% · guest 100%9:00 · the partners 0% · guest 100%9:00 · the partners 0% · guest 100%12:00 · the partners 0% · guest 100%12:00 · the partners 0% · guest 100%15:00 · the partners 0% · guest 100%15:00 · the partners 0% · guest 100%18:00 · the partners 0% · guest 100%18:00 · the partners 0% · guest 100%21:00 · the partners 0% · guest 100%21:00 · the partners 0% · guest 100%24:00 · the partners 0% · guest 100%24:00 · the partners 0% · guest 100%27:00 · the partners 0% · guest 100%27:00 · the partners 0% · guest 100%30:00 · the partners 0% · guest 100%30:00 · the partners 0% · guest 100%33:00 · the partners 0% · guest 100%33:00 · the partners 0% · guest 100%36:00 · the partners 0% · guest 100%36:00 · the partners 0% · guest 100%39:00 · the partners 0% · guest 100%39:00 · the partners 0% · guest 100%42:00 · the partners 0% · guest 100%42:00 · the partners 0% · guest 100%45:00 · the partners 0% · guest 100%45:00 · the partners 0% · guest 100%48:00 · the partners 0% · guest 100%48:00 · the partners 0% · guest 100%51:00 · the partners 0% · guest 100%51:00 · the partners 0% · guest 100%54:00 · the partners 0% · guest 100%54:00 · the partners 0% · guest 100%57:00 · the partners 0% · guest 100%57:00 · the partners 0% · guest 100%1:00:00 · the partners 0% · guest 100%1:00:00 · the partners 0% · guest 100%1:03:00 · the partners 0% · guest 100%1:03:00 · the partners 0% · guest 100%
Sharpest disagreement ▶ 27:27 Reframing market failure as local regulatory blockade

David directly rejects the host's premise that a single dominant retail brand has not emerged due to natural market forces, explaining that 67% of California municipalities ban cannabis commerce.

Hardest push from the partners ▶ 26:09 Pressing on the lack of a cannabis retail giant

Craig refuses to accept that fragmentation explains everything, pushing back to demand why even within California there is no CVS or Marlboro equivalent of cannabis.

Biggest teaching moment ▶ 12:14 Comprehensive schooling on cannabinoids and extraction

Vincent and David deliver a masterclass on cannabidiol, detailing hemp versus marijuana legality, non-psychoactive properties, and the entourage effect across hundreds of plant cannabinoids.

The partners hold their own ▶ 52:02 Host connects cannabis stigma cycle to psychedelic research

Craig actively synthesizes the discussion by citing Michael Pollan's psychedelic research, drawing parallels between cannabis normalization and clinical trials for trauma.

the scores for every segment, with the reasoning behind each
ChapterTopicThe partners as informed peerGuest teachingGuest disagreementThe partners pushing backWhy
Third-Party Cannabis Distribution Model 1710 Craig asks basic questions about strain aroma indicating strain or potency. David Hua and Vincent Ning educate him on terpene profiles, sativas vs indicas, and how live resin concentrates are made and measured.
Microdosing and Edible Trends for New Consumers 2611 Craig shares his own experience with low-dose edibles versus smoking. The guests break down liver metabolization, onset timing, vape concentrates, and how microdosing caters to the modern mainstream consumer.
Demographics and the Rise of Baby Boomers 1810 Craig prompts for demographic trends and asks for an explanation of CBD. David and Vincent explain the surge in baby boomer adoption and break down the science of cannabinoids and the entourage effect.
Terpene Lexicon and Extraction Methods 1710 Craig asks how specific compounds like CBD are isolated without pulling other elements. David gives a technical rundown of solventless ice-water hash methods versus chemical extractions like CO2 and butane distillation.
Business Models: Meadow and Nabus 2600 Craig inquires why both founders avoided direct product manufacturing. Vincent details the capital-intensive nature of equipment and the friction around fundraising with a Type 11 distribution license.
Y Combinator Experience and Pitch Strategy 3500 Craig and David discuss the Y Combinator interview process for cannabis software and the transition from Prop 215 paperless practices to 7-year compliance tracking.
Investor Mindset & Due Diligence 2500 Craig asks about investor composition and industry growth stats. The guests explain rolling angel raises, investor educational diligence, and California's historical share of total US supply.
California Market Dominance & Local Regulatory Hurdles 2721 Craig questions why there is no dominant national or statewide brand like Marlboro or Budweiser. David and Vincent explain the fragmented dual-licensing regime where municipal opt-outs strangle supply chains.
State Comparisons and Canadian Federal Legalization 2600 Craig asks about other states and Canada. David and Vincent explain the influx of capital from publicly listed Canadian licensed producers moving into California.
The Banking Crisis in the Cannabis Industry 2600 Craig asks how operators bank cash without federal FDIC support. Vincent and David outline credit unions, multiple accounts, and pending delivery regulations allowing mobile inventory.
Warehouse Logistics and Distributor Responsibilities 1700 Craig is surprised to hear raw flower arrives in trash bags. Vincent clarifies the legal mandate that makes distributors the sole tax and compliance gatekeepers between farms and dispensaries.
Taxation Burden and Illicit Market Resurgence 2710 Craig asks if farmers capture the upside of retail prices. David and Vincent show how compounding cultivation, excise, and gross receipt taxes force medical consumers back to the illicit market.
Medical Cards vs Adult-Use Realities 2600 Craig asks why anyone still gets medical cards. David and Vincent describe the high card fees, Phase 2 pesticide testing wipeouts, and dispensary demo day marketing dynamics.
Future Outlook: Regulation, Interstate Expansion, and M&A 2600 Craig prompts for a 5-to-10-year industry vision. Vincent outlines the interstate expansion barrier requiring siloed state-level entities and predatory Canadian M&A structures.
Long-Term Vision: Unlimited Grows and Corporate Entry 2710 David details the impending expiration of the 1-acre grow cap in 2023, the rise of corporate alcohol/tobacco conglomerates, and comparisons to the dot-com bubble.
Cultural Evolution, Stigma, and Media Shift 2510 Craig asks if stoner stereotypes like Cheech & Chong hurt or helped the movement. Vincent and David discuss historical advocacy, digital advertising bans, and mainstreaming via public figures.
Medical Origins, Psychedelic Parallels, and Social Equity 3700 Craig brings up Michael Pollan's book on psychedelics and social equity. David and Vincent explain Prop 215's roots in the San Francisco AIDS crisis, SB 1294 grant funding, and municipal social equity quotas.

Statements from this episode (31)

Opinion
Hua: Evaluating cannabis terpenes is comparable to wine tasting
“I figured we would be able to smell a lot of different flowers so you can get the terpene profiles. I think it's kind of like when you do wine tastings. So I think that's important.”
David Hua Oct 11, 2018 ▶ 0:18
Insight
Ning: Extensive crossbreeding makes nearly all modern cannabis strains hybrids
“But then at the end of the day, there's so many different varieties of strains that and nowadays with the crossbreeding of all them, everything seems to be somewhat of a hybrid a strain.”
Vincent Ning Oct 11, 2018 ▶ 3:06
Assertion Not checkable as stated
Hua: New cannabis consumers prefer low-dose edibles over high-potency dabs
“These are like gourmet, low dose, and that's what kind of the new consumer is going after. They're not trying to get blitzed on a dab.”
David Hua Oct 11, 2018 ▶ 4:41
Insight
Hua: Cannabis-induced anxiety is usually caused by excessive dosing
“And most people, you know, when they get too paranoid or they get a little bit like anxious, they just did way too much. They have to just, they're just way sensitive. So dial it back, keep dialing it back until you can then add a little bit more.”
David Hua Oct 11, 2018 ▶ 5:51
Assertion Not checkable as stated
Hua: Baby boomers are the fastest-growing cannabis customer demographic
“The fastest demographic we're seeing is actually the baby boomers.”
David Hua Oct 11, 2018 ▶ 10:07
Assertion Not checkable as stated
Hua: Baby boomers are using cannabis to replace prescription drugs
“You know, they're replacing a lot of their prescription drugs.”
David Hua Oct 11, 2018 ▶ 10:15
Assertion Supported
Ning: Hemp CBD is legally sold anywhere unlike marijuana-derived CBD
“And so the hemp based CBD is legal and you can sell that anywhere. So you can get it at like Costco if you want. I've seen like hemp lotion and like all that sort of stuff. But then there's also just like CBD products that are derived from marijuana that can b…”
Vincent Ning Oct 11, 2018 ▶ 11:37
Assertion Not checkable as stated
Hua: Hemp CBD lacks the entourage effect of multi-cannabinoid formulations
“And with CBD especially if you just take it from hemp derived, the problem is there, you don't have this, what they call the entourage effect. And What that pretty much means is each of the cannabinoids kind of help each other with the fact. And so that's why …”
David Hua Oct 11, 2018 ▶ 13:19
Assertion Not checkable as stated
Ning: Cannabis products are shifting from strain-based to effects-based marketing
“And like products nowadays apart from just being strain based as what you would normally buy back in the day, you're like, I'll buy some blue dream or some of this or, and based on strain now a lot of products are ratio based or like effects based. So they'll …”
Vincent Ning Oct 11, 2018 ▶ 13:52
Insight
Ning: Vice clauses in LP agreements block institutional VCs from cannabis
“For a lot of institutions that can write larger check sizes they have LPs for their funds that basically they sign LP agreements that say, like, you can't invest in certain vice industries like gambling or alcohol or Weed, of course.”
Vincent Ning Oct 11, 2018 ▶ 18:44
Assertion Supported
Hua: Meadow was the first cannabis startup to go through YC
“Which I think is an unfair advantage, but we were the first company to go through.”
David Hua Oct 11, 2018 ▶ 19:10
Assertion Not checkable as stated
Hua: 90% of California cannabis dispensaries are mom-and-pop shops
“I mean, 90% of the shops are mom and pop right now in California.”
David Hua Oct 11, 2018 ▶ 19:58
Disclosure
Hua: Meadow raised $2.5M on a $12M cap after YC
“Raised two and a half on 12. And so we came out of YC. It took, you know, we didn't close it up all after demo day. It took probably around nine months.”
David Hua Oct 11, 2018 ▶ 22:34
Assertion Partly supported
Ning: 80% of US cannabis historically came from California
“A couple years ago including the black market, 80% of the cannabis in the United States came out of California”
Vincent Ning Oct 11, 2018 ▶ 24:05
Prediction Partly held up
Hua: California adult-use sales will hit $3B while medical collapses
“Last year we probably did three billion dollars in medical sales. This year we'll probably do as much of that in adult use sales and medical will be a fraction of that. Maybe, you know, half a billion if we get there.”
David Hua Oct 11, 2018 ▶ 27:30
Assertion Supported
Hua: 67% of California lacks local regulations, blocking state cannabis permits
“33% of the state that has some form of local laws, and then 67% of the state that has no laws whatsoever. And because of that, you have this disconnect between state law where you can get your permits, but you can't get a permit unless you get your local permi…”
David Hua Oct 11, 2018 ▶ 27:45
Prediction Didn’t hold up
Ning: Well-capitalized Canadian public companies will drive US cannabis consolidation
“I think part of the whole like consolidation pattern that will Come just because the market's so fragmented right now will be heavily pressurized by Canadian like publicly traded, heavily capitalized companies. Just because they're coming in and they're buying…”
Vincent Ning Oct 11, 2018 ▶ 30:16
Disclosure
Ning: Over 90% of transactions for cannabis distributor Nabis are cash
“Cause you touched on earlier, more than I would say for us, at least more than 90% of our transactions are in cold, hard cash.”
Vincent Ning Oct 11, 2018 ▶ 31:29
Assertion Supported
Hua: Proposed rules allow cannabis delivery into locally banned California cities
“And in that this iteration, there was a proposed reg on allowing delivery operators to deliver anywhere into the state, even in prohibited areas, which is in contention with the chiefs of police, the league of cities that California definitely prides itself on…”
David Hua Oct 11, 2018 ▶ 32:41
Assertion Supported
Ning: California requires a licensed distributor for all B2B cannabis transit
“No one can move product between two different license entities without a distributor. So even if you're just like a farm moving your product to a manufacturer, you have to contract out a distributor or get your own distributor's license in order to move it.”
Vincent Ning Oct 11, 2018 ▶ 34:18
Assertion Supported
Hua: Legalization pushed medical cannabis patients into the illicit market
“The irony of legalization is that there's a lot of medical patients have gone and turned to the illicit market for their products.”
David Hua Oct 11, 2018 ▶ 37:07
Insight
Ning: Dispensary sales are driven by marketing budgets and budtender training
“Whoever has the higher marketing budget will go in and just buy out shelves for The dispensary, like, shelf space at the dispensary, and they'll teach all the bud tenders at, you know, all the major locations, and that's what'll get pushed through the most.”
Vincent Ning Oct 11, 2018 ▶ 40:20
Assertion Supported
Ning: Compliance forced dispensaries to video-record destroying millions in cannabis
“Well, because for compliance, you have to record yourself disposing of the product, whether you burn it or smash it or whatever. There's videos of dispensaries just like as evidence, just like damaging all their products and just basically having this huge dem…”
Vincent Ning Oct 11, 2018 ▶ 41:23
Prediction Not checkable as stated
Ning: Federal cannabis reform remains several years away despite state progress
“I think it'll probably be another few years before anything federally changes. And more and more states will continue to pass favorable regulations towards cannabis. So a lot of them will start out by decriminalizing it and then making it medicinally available…”
Vincent Ning Oct 11, 2018 ▶ 42:53
Disclosure
Ning: Nabis expands interstate via segregated entities to avoid federal law
“Although we're currently in California, we actually have to set up a different legal entity in each state so that we segregate out our business so it's not interstate commerce and, you know, basically expand that way from state to state, and then have, like, a…”
Vincent Ning Oct 11, 2018 ▶ 43:23
Assertion Not checkable as stated
Ning: Canadian firms acquire US cannabis distributors for licenses, slash staff
“We have seen some, like, distribution companies at least get bought out by Canadian companies, and I think it's hugely just, like stock packages and, like, The C levels will go join the company and then the rest of the company kind of gets let go. And so it's …”
Vincent Ning Oct 11, 2018 ▶ 44:08
Assertion Supported
Hua: California will remove the one-acre cannabis cultivation cap in 2023
“There is something that happens in twenty-twenty-three with the laws that allow that removes a one-acre cap. you know, right now, if you're growing, you have a one-acre cap that you can grow in. However, people have been doing stacking, so they get a bunch of…”
David Hua Oct 11, 2018 ▶ 45:00
Opinion
Hua: Canadian cannabis public markets resemble the dot-com bubble
“It's feeling very frothy right now if you look at the Canadian markets. but there's, because there's only so limited access to invest, that capital flow keeps coming. It very much feels like the internet Dot com like bubble that was getting created. And sure …”
David Hua Oct 11, 2018 ▶ 47:56
Prediction Not checkable as stated
Hua: Spain and Germany will become major global cannabis players
“I think you're also going to see a lot more exporting globally. you're already seeing contracts being made with Canada and other countries. I think you're going to see a rise in Spain and Germany. they're going to be coming out and being bigger players”
David Hua Oct 11, 2018 ▶ 48:35
Assertion Contradicted
Hua: San Francisco requires a 30% social equity workforce for cannabis
“Within San Francisco. You're gonna need to hire 30% of your workforce from social equity people. You also, as a dispensary, may need to have a certain amount or certain percentage of your shelf space of products created and manufactured by people from social e…”
David Hua Oct 11, 2018 ▶ 59:38
Disclosure
Ning: Nabis founders personally drove hundreds of thousands in unregulated weed
“I when we first started this we had a friend who basically ran, like, a pre-roll company that was distributing across California, and prior to regulation, this year is very much just like a backpacking industry where people would deliver their own products to …”
Vincent Ning Oct 11, 2018 ▶ 1:01:10
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 300 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.